2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for JAZZ PHARMACEUTICALS INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 6 - 21st Century Cures ***, no specific bills, drug safety, prescription drug abuse, Innovation

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
ELIZABETH T MURRAY New Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
LINDA E TARPLIN Sp. Asst. to the Pres. for Leg. Affairs; Dep. Asst. Sec. for Leg. - HHS
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Copyright/Patent/Trademark CPT

H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
ELIZABETH T MURRAY —
LINDA E TARPLIN —
JENNIFER B YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1137 (114th), S. 779 (114th), H.R. 9 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.